Please try another search
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through gene editing, cellular regeneration, and gene addition. The company is developing TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy which is in phase 1 clinical trial; TN-301, a small molecule for heart failure with preserved ejection fraction which is in phase 1 clinical trial; and TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy which is in preclinical stage. It also develops an adeno-associated virus-based gene therapy designed to deliver the dworf gene for patient with dilated cardiomyopathy; and reprogramming program for heart failure due to prior myocardial infarction. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Name | Age | Since | Title |
---|---|---|---|
Jin-Long Chen | 61 | 2016 | Independent Director |
David V. Goeddel | 72 | 2016 | Independent Chairman of the Board |
June H. Lee | 58 | 2021 | Independent Director |
Jeffrey T. Walsh | 58 | 2020 | Independent Director |
Douglas L. Mann | - | - | Member of Scientific Advisory Board |
Amy L. Burroughs | 53 | 2022 | Independent Director |
Alexander Marson | - | 2023 | Member of Scientific Advisory Board |
Elizabeth McNally | - | - | Member of Scientific Advisory Board |
R. Sanders Williams | 75 | 2016 | Independent Director |
Mark A. Kay | 65 | - | Member of Scientific Advisory Board |
Jonathan S. Weissman | - | - | Member of Scientific Advisory Board |
Karah Herdman Parschauer | 46 | 2021 | Independent Director |
Catherine Stehman-Breen | 61 | 2020 | Independent Director |
Christine Edry Seidman | - | 2023 | Member of Scientific Advisory Board |
Faraz Ali | 51 | 2018 | CEO & Director |
Eric N. Olson | - | - | Scientific Founder & Member of Scientific Advisory Board |
Deepak Srivastava | 57 | 2016 | Scientific Founder, Chairman of Scientific Advisory Board & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review